Monoclonal therapeutics and diagnostic antibodies market worth $56 billion by 2012
The monoclonal therapeutic and diagnostic antibodies market is expected to increase by 80% by 2012, according to a technical market research report by BCC Research.
Titled Monoclonal Therapeutics and Diagnostic Imaging Products: The Global Market (Bio016g), the report showed the global market for monoclonal therapeutic and diagnostic antibodies was worth $31 billion in 2007. This is expected to increase to over $56 billion by 2012, a compound average annual growth rate (CAGR) of 13%.
For more information on the report, visit www.bccresearch.com.
Testing more antibodies with fewer lab mice
Researchers have developed a technology that can be used to test 25 antibodies simultaneously in...
Nanofibre uniform protects soldiers against chemical threats
A next-generation uniform prototype employs nanofibres to safeguard wearers from chemical and...
Monoclonal antibody shows protection against COVID variants
A monoclonal antibody appears effective at neutralising the numerous variants of SARS-CoV-2, as...
